Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Change in Receivables (2018 - 2025)

Health Catalyst's Change in Receivables history spans 8 years, with the latest figure at -$900000.0 for Q4 2025.

  • For Q4 2025, Change in Receivables fell 144.49% year-over-year to -$900000.0; the TTM value through Dec 2025 reached $1.8 million, up 142.26%, while the annual FY2025 figure was $1.8 million, 142.26% up from the prior year.
  • Change in Receivables reached -$900000.0 in Q4 2025 per HCAT's latest filing, up from -$7.9 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $15.4 million in Q1 2023 to a low of -$9.5 million in Q2 2023.
  • Average Change in Receivables over 5 years is $515050.0, with a median of $412500.0 recorded in 2021.
  • Peak YoY movement for Change in Receivables: skyrocketed 2327.66% in 2022, then plummeted 395.85% in 2023.
  • A 5-year view of Change in Receivables shows it stood at $919000.0 in 2021, then crashed by 272.8% to -$1.6 million in 2022, then surged by 976.7% to $13.9 million in 2023, then tumbled by 85.47% to $2.0 million in 2024, then tumbled by 144.49% to -$900000.0 in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Change in Receivables are -$900000.0 (Q4 2025), -$7.9 million (Q3 2025), and $4.6 million (Q2 2025).